Phreesia Gross Margin 2019-2025 | PHR
Current and historical gross margin for Phreesia (PHR) over the last 10 years. The current gross profit margin for Phreesia as of April 30, 2025 is %.
| Phreesia Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-04-30 | $0.44B | $0.30B | 67.82% |
| 2025-01-31 | $0.42B | $0.28B | 67.62% |
| 2024-10-31 | $0.41B | $0.27B | 66.91% |
| 2024-07-31 | $0.39B | $0.26B | 66.67% |
| 2024-04-30 | $0.37B | $0.25B | 66.04% |
| 2024-01-31 | $0.36B | $0.23B | 65.27% |
| 2023-10-31 | $0.34B | $0.22B | 64.60% |
| 2023-07-31 | $0.32B | $0.20B | 63.75% |
| 2023-04-30 | $0.30B | $0.19B | 62.25% |
| 2023-01-31 | $0.28B | $0.17B | 61.21% |
| 2022-10-31 | $0.26B | $0.16B | 60.69% |
| 2022-07-31 | $0.25B | $0.15B | 60.41% |
| 2022-04-30 | $0.23B | $0.14B | 60.96% |
| 2022-01-31 | $0.21B | $0.13B | 61.97% |
| 2021-10-31 | $0.20B | $0.12B | 62.44% |
| 2021-07-31 | $0.18B | $0.11B | 62.57% |
| 2021-04-30 | $0.16B | $0.10B | 63.80% |
| 2021-01-31 | $0.15B | $0.10B | 64.86% |
| 2020-10-31 | $0.14B | $0.09B | 65.47% |
| 2020-07-31 | $0.13B | $0.09B | 66.42% |
| 2020-04-30 | $0.13B | $0.09B | 66.15% |
| 2020-01-31 | $0.13B | $0.08B | 64.80% |
| 2019-07-31 | $0.08B | $0.05B | 63.10% |
| 2019-04-30 | $0.08B | $0.05B | 62.82% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.527B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.989B | 58.51 |
| Hims & Hers Health (HIMS) | United States | $13.669B | 142.02 |
| Tempus AI (TEM) | United States | $11.962B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.646B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.825B | 59.77 |
| Hinge Health (HNGE) | United States | $3.100B | 0.00 |
| Privia Health (PRVA) | United States | $2.659B | 181.75 |
| Enovis (ENOV) | United States | $1.751B | 9.76 |
| Schrodinger (SDGR) | United States | $1.545B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Azenta (AZTA) | United States | $1.371B | 63.70 |
| 10x Genomics (TXG) | United States | $1.338B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Claritev (CTEV) | United States | $0.663B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| Outset Medical (OM) | United States | $0.347B | 0.00 |
| TruBridge (TBRG) | United States | $0.346B | 766.67 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.139B | 0.00 |
| Pulmonx (LUNG) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |